Key facts
- This page summarizes Megan Colligan)'s Form 4 filing for IMAX CORP (IMAX).
- 12 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2023, 15:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Tax liability
Award
Tax liability
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Award
Additional SEC filing notes
Footnote F1
Represents the conversion upon vesting of restricted share units into common shares.
Footnote F2
Ms. Colligan is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
Footnote F3
Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2020. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
Footnote F4
Ms. Colligan is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.
Footnote F5
Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
Footnote F6
Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
Footnote F7
The restricted share units vest and will be converted to common shares in three installments: 25,269 on each of March 7, 2021 and March 7, 2022 and 25,270 on March 7, 2023.
Footnote F8
The restricted share units vest and will be converted to common shares in two equal installments on each of the first two anniversaries of the grant date.
Footnote F9
The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.
Footnote F10
The restricted share units vest and will be converted to common shares in three installments: 14,019 on each of March 7, 2023 and March 7, 2024 and 14,020 on March 7, 2025.
Footnote F11
The restricted share units vest and will be converted to common shares in three installments: 13,404 on each of March 7, 2024 and March 7, 2025 and 13,406 on March 7, 2026.
Footnote F12
This represents the number of restricted share units for this transaction only. Ms. Colligan's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 124,573, 83,494 and 119,434, respectively.